NGS cancer panels

Explore fixed and custom research panels targeting known variants for cancer-related genes.

Targeted panels tailored for cancer research

Illumina offers a broad portfolio of cancer-focused next-generation sequencing (NGS) panels across multiple application areas. These products have been optimized with clinical cancer research in mind. Achieve sequence-ready libraries from as little as 1 ng of high-quality input or 10 ng formalin-fixed paraffin-embedded (FFPE) sample using efficient, optimized assays and integrated sequencing and bioinformatics. Our comprehensive offering includes both fixed panels and custom options.

Related content